TrialEpilepsia open2025

Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy.

Jacqueline A French et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.